Cargando…
Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic
BACKGROUND: Infection with the novel coronavirus SARS‐CoV‐2 induces antibodies that can be used as a proxy for COVID‐19. We present a repeated nationwide cross‐sectional study assessing the seroprevalence of SARS‐CoV‐2, the infection fatality rate (IFR), and infection hospitalization rate (IHR) duri...
Autores principales: | Tunheim, Gro, Rø, Gunnar Øyvind Isaksson, Tran, Trung, Kran, Anne‐Marte Bakken, Andersen, Jan Terje, Vaage, Eline Benno, Kolderup, Anette, Vaage, John Torgils, Lund‐Johansen, Fridtjof, Hungnes, Olav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652705/ https://www.ncbi.nlm.nih.gov/pubmed/34751488 http://dx.doi.org/10.1111/irv.12932 |
Ejemplares similares
-
Prevalence of antibodies against SARS‐CoV‐2 in the Norwegian population, August 2021
por: Tunheim, Gro, et al.
Publicado: (2022) -
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
por: König, Marton, et al.
Publicado: (2022) -
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
por: König, Marton, et al.
Publicado: (2023) -
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
por: Kared, Hassen, et al.
Publicado: (2022) -
Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study
por: Laake, Ida, et al.
Publicado: (2018)